Page Loading...
Layout Table~~~~2443~2443~~
High-Content Analysis 2007~
Published by Select Biosciences, April 2007
This report presents an industry analysis of the High-Content Analysis Marketplace in both qualitative and quantitative terms. High-Content Analysis involves the use of instrumentation, reagents, and informatics to perform multi-parametric analysis of biological systems—ie., lots of different cellular parameters studied in parallel. High-Content Analysis is crucial in the biological characterization [fine-structure characterization] of lead compounds primarily in the drug discovery process. Select Biosciences’ industry tracking of this space involves analyses of the technology trends as well as market analysis of instrumentation and reagents that are utilized in High-Content Analysis. Select Biosciences presents primary market survey data in this report that describe important qualitative and quantitative metrics in the High-Content Analysis marketplace—these parameters describe the marketplace in detail.~Published by Select Biosciences, April 2007
This report presents an industry analysis of the High-Content Analysis Marketplace in both qualitative and quantitative terms. High-Content Analysis involves the use of instrumentation, reagents, and informatics to perform multi-parametric analysis of biological systems—ie., lots of different cellular parameters studied in parallel. High-Content Analysis is crucial in the biological characterization [fine-structure characterization] of lead compounds primarily in the drug discovery process. Select Biosciences’ industry tracking of this space involves analyses of the technology trends as well as market analysis of instrumentation and reagents that are utilized in High-Content Analysis. Select Biosciences presents primary market survey data in this report that describe important qualitative and quantitative metrics in the High-Content Analysis marketplace—these parameters describe the marketplace in detail.
Topics Covered in This Report
Discussion of the High-Content Analysis Space—Instrumentation and Reagent/Assay Platforms
Market Analysis of the High-Content Analysis Space—Primary Market Research Data describing Various Industry Parameters that Together Describe the Market Structure in Detail
Market Size, Growth Rates, and Opportunity in High-Content Analysis
Key Technologies for High-Content Analysis
Commercial Products and Formats for High-Content Analysis
Qualitative Presentation of Challenges, Bottlenecks, and Drivers in High-Content Analysis
Table of Contents
~High-Content Analysis 2007 (Single User Print License)|1003|High-Content Analysis 2007 (Electronic Site License)|1004|~2443~3135~~
Ion Channel Trends 2006~
Published by HTStec Limited, July 2006
This market report summarizes the results of the third annual global Pharma/Biotech and Academic web-based benchmarking survey on ion channels. The objectives of this study were to better understand the impact of automated patch clamping (APC) and to gauge if its use will widen over the coming years, and to determine current interest and future requirements for ion channel screening using primary neural cells. The survey looked at various points including current use and experience of APC systems; areas where APC systems have been implemented; application areas where APC systems are expected to impact most; how respondents source human neuronal cells; what is preventing greater use and the timescale to use these cells; annual budgets for ion channel related cell lines and cell culture media and interest in accessing new neural cell products.~Published by HTStec Limited, July 2006
This market report summarizes the results of the third annual global Pharma/Biotech and Academic web-based benchmarking survey on ion channels. The objectives of this study were to better understand the impact of automated patch clamping (APC) and to gauge if its use will widen over the coming years, and to determine current interest and future requirements for ion channel screening using primary neural cells.
The survey looked at various points including current use and experience of APC systems; areas where APC systems have been implemented; application areas where APC systems are expected to impact most; how respondents source human neuronal cells; what is preventing greater use and the timescale to use these cells; annual budgets for ion channel related cell lines and cell culture media and interest in accessing new neural cell products.
Table of Contents
~Ion Channel Trends 2006 Electronic Site License (PDF)|506|~2443~2552~~
U.S. and Western European In Silico ADME/Tox Products Market 2006~
Published by Select Biosciences, June 2006
In Silico predictive ADME/Tox screening is one of the hottest areas in drug discovery. It is widely perceived that the early screening of chemical entities can significantly reduce the expensive costs associated with late stage failures of drugs due to poor ADME/Tox properties. This market research report from Select Biosciences provides and up-to-date overview and analysis of technology, business, regulatory trends and key product profiles.~
Published by Select Biosciences, June 2006
In Silico predictive ADME/Tox screening is one of the hottest areas in drug discovery. It is widely perceived that the early screening of chemical entities can significantly reduce the expensive costs associated with late stage failures of drugs due to poor ADME/Tox properties. This market research report from Select Biosciences provides and up-to-date overview and analysis of technology, business, regulatory trends and key product profiles.
In this report Select Biosciences presents an analysis of the In Silico ADME/Tox market landscape. Although, the market is at an embryonic stage of development, the insurgence in the number of companies and products offered to this market clearly reflects significant opportunity.
Furthermore, in this report qualitative and quantitative market analysis of In Silico ADME/Tox products is presented. Also presented is the potential market opportunity, and the various factors that are driving and/or restraining the growth of this market.~U.S. and Western European In Silico ADME/Tox Products Market 2006 (Single User Version)|13|U.S. and Western European In Silico ADME/Tox Products Market 2006 (Eletronic Site License)|620|~2443~2444~~
Cell Culture Vessels Trends 2006~
Published by HTStec, February 2006
This market report summarizes the results of a comprehensive global Pharma/Biotech web-based survey on the current and future status of cell culture vessel trends. The survey covered areas including respondents’ responsibilities to purchase cell culture vessel manufacturers/distributors with preferred supplier status; relative ranking of these manufacturers/distributors on basis of annual budget spend, annual usage for both different types and specialized cell culture vessels; interest in new cell culture specific chemistries; unmet needs in cell culture vessels and specific coatings together with interest in Transwell permeable supports and other Transwell products.~
Published by HTStec, February 2006
This market report summarizes the results of a comprehensive global Pharma/Biotech web-based survey on the current and future status of cell culture vessel trends. The survey covered areas including respondents’ responsibilities to purchase cell culture vessel manufacturers/distributors with preferred supplier status; relative ranking of these manufacturers/distributors on basis of annual budget spend, annual usage for both different types and specialized cell culture vessels; interest in new cell culture specific chemistries; unmet needs in cell culture vessels and specific coatings together with interest in Transwell permeable supports and other Transwell products.
Table of contents
~Cell Culture Vessels Trends 2006|739|~2443~2676~~
Secondary Screening~
Published by Select Biosciences, October 2003
Quantitative market model segmented by re-screening, toxicology, and ADME
Detailed assessment of competitive landscape, including 40 company evaluations
Analysis of key drivers and trends in a complex and dynamic industry
~Published by Select Biosciences, October 2003
Quantitative market model segmented by re-screening, toxicology, and ADME
Detailed assessment of competitive landscape, including 40 company evaluations
Analysis of key drivers and trends in a complex and dynamic industry
90% of compounds fail in drug development because of four reasons. 41% of those fail because of poor ADME; 31% because of insufficient efficacy; 22% because of toxicity; and only 6% because of market and/or commercialization complications. The earlier in the development process that an inadequate compound can be removed, the less time and money wasted, usually on the order of five to ten years and hundreds of millions of dollars.~Secondary Screening%3A Chapter 1%3A Excutive Summary (PDF)|78|Secondary Screening%3A Chapter 2%3A SEcondary Screening Space (PDF)|79|Secondary Screening%3A Chapter 3%3A Market Analysis (PDF)|80|Secondary Screening%3A Chapter 4%3A Competitive Landscape (PDF)|81|Secondary Screening%3A Full Report - PDF Site License + 1 Print Copy|82|Secondary Screening%3A Full Report - Single User Print Version|83|~2443~2448~~
Menu Page
|
Toolbar Page
|
Frameset Page
|
Index Page
|
Table of Contents
EROL - Electronic Retail Online E-commerce shopping cart software